ANGO Financial Facts

Income tax provision: 1.6M
Diluted weighted average shares outstanding: 36.7M
See Full Income Statement

Inventories: 58.27M
Total liabilities: 213.99M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 10/2/26 *Est. EPS Growth Rate -133.3% *Last Qtr.
Average EPS % Beat Rate +40.3% Revenue Growth Rate +8.0% *Last Qtr.
Average % Move 1-Wk after EPS -1.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/14/26 Q426 -$0.07-$0.09 +$0.02$86.61M$80.24M = Details
4/2/26 Q326 -$0.07-$0.09 +$0.02$78.42M$76.71M = Details
1/6/26 Q226 $0.00-$0.10 +$0.10$79.4M$76.3M = Details
10/2/25 Q126 -$0.10-$0.12 +$0.02$75.7M$72.7M = Details
7/15/25 Q425 -$0.03-$0.12 +$0.09$80.2M$74.27M = Details
4/2/25 Q325 $0.03-$0.11 +$0.14$72M$70.57M = Details
1/8/25 Q225 -$0.04-$0.11 +$0.07$73M$70.93M = Details
10/3/24 Q125 -$0.11-$0.16 +$0.05$67.5M$69M = Details